Price target
1,033.290.000.00%
The 22 analysts offering 1 year price forecasts for 4REGN have a max estimate of — and a min estimate of —.
Analyst rating
Based on 28 analysts giving stock ratings to 4REGN in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
4REGN EPS for the last quarter is 11.19 EUR despite the estimation of 10.50 EUR. In the next quarter EPS is expected to reach 10.86 EUR. Track more of REGENERON PHARMACEUTICALS financials and stay on top of what is up with the company.
In the next quarter REGENERON PHARMACEUTICALS revenue is expected to reach 3.62 B EUR. Check out REGENERON PHARMACEUTICALS revenue and earnings and make informed decisions.
According to analysts, 4REGN price target is 1,033.29 EUR with a max estimate of 1,182.58 EUR and a min estimate of 543.22 EUR. Check if this forecast comes true in a year, meanwhile watch REGENERON PHARMACEUTICALS stock price chart and keep track of the current situation with 4REGN news and stock market news.
We've gathered opinions of 28 analysts rating 4REGN stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.